Tue, 3/26 2019: 1:00 PM
- 2:00 PM
Regularly Scheduled Series
This webinar will give an overview of how the FDA conducts pharmacovigilance activities, detect safety signals, and communicates safety findings.
Define pharmacovigilance|Describe the Division of Pharmacovigilance’s (DPV’s) key safety roles in FDA’s Center for Drug Evaluation and Research (CDER)|Explain components of postmarketing drug safety surveillance|Describe the role of MedWatch for reporting postmarketing safety information|Discuss how adverse event reports are collected and analyzed by FDA/CDER/DPV